Trending Now
Real Brands Inc (OTCMKTS:RLBD) is a Major Squeeze Candidate in the...
Real Brands Inc (OTCMKTS:RLBD) is an emerging player on the rejuvenating CBD stock landscape, and one that may deserve attention as a...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Crypto Stocks Enter a New Age (CAN, RIOT, ISWH, MARA)
The Cryptocurrency boom that got full-throated traction last fall has only accelerated, and the key point in play is legitimacy.
MAKE IT MODERN
LATEST REVIEWS
Onconova Therapeutics Inc. (NASDAQ: ONTX) Releases Safety And Efficacy Data of...
Onconova Therapeutics Inc. (NASDAQ: ONTX) has releases interim efficacy and safety data from the investigator-initiated Phase 1/2, a study of oral rigosertib combination with...
MAKE IT MODERN
PERFORMANCE TRAINING
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Will Publish First Data Of TNX-1800 From Animal Study...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) expects to report first data from TNX-1800, the lead vaccine candidate for coronavirus, in animals in Q4 2020. The...
Akebia Therapeutics Inc. (NASDAQ:AKBA) Publishes INNO2VATE Program In The Nephrology Dialysis Transplantation (NDT) Journal
Akebia Therapeutics Inc. (NASDAQ:AKBA) has announced the publication of details of its study design and methodology of the global third phase INNO2VATE program in...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Enters Commercialization Agreement with Otsuka Pharmaceuticals for Voclosporin
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has announced the signing of a collaboration and license agreement with Otsuka Pharmaceutical Co. Ltd. The agreement is...
Ascendis Pharma A/S (NASDAQ: ASND) Receives FDA Approval For SKYTROFA In Paediatric GHD...
Ascendis Pharma A/S (NASDAQ: ASND) has approval for SKYTROFA (lonapegsomatropinc-tcgd) in pediatric patient treatment for those above one year and weighing 11.5 Kg that...
Junior Miner Blue Lagoon (BLAGF) Poised for Promising Non-Dilutive Exploration Push as New Gold...
After wallowing in a sideways consolidation for the past two years, gold is breaking out once again. The yellow metal blew through...
MAKE IT MODERN
